Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Veronese Ventures is an investment organization founded by Roberto Veronese in 2022, located in San Francisco. The firm operates as a solo general partner (GP) and angel investment vehicle, focusing on early- and mid-stage companies in the digital health and biotech sectors. Roberto Veronese brings over a decade of experience in genomics and AI-driven precision medicine, aiming to support startups that are transforming healthcare.
Since its inception, Veronese Ventures has positioned itself as a key player in the investment landscape, emphasizing the integration of AI and genomics in healthcare solutions. The firm not only invests capital but also provides strategic insights and advisory services to enhance product strategy, market research, and customer experience design for its portfolio companies. This dual approach allows Veronese Ventures to add significant value beyond financial investment.
As of now, the firm has a notable portfolio company, ArteraAI, where Roberto serves in an advisory capacity. Veronese Ventures continues to seek innovative startups that align with its focus areas, leveraging its expertise to guide them through the complexities of the healthcare market.
Veronese Ventures primarily invests in startups within the digital health, biotech, and precision medicine sectors. The firm emphasizes the application of AI in healthcare, aiming to enhance solutions that address critical challenges in these fields. Investment stages include angel, pre-seed, seed, seed-plus, and series A, allowing for flexibility in supporting companies at various points in their development.
The organization seeks to partner with founders who are not only innovative but also possess a strong understanding of their market and product. Veronese Ventures provides advisory services that focus on product strategy, market research, and customer experience design, ensuring that portfolio companies are well-equipped to navigate their respective markets. The firm operates primarily in North America, targeting startups that can leverage AI and genomics to create impactful healthcare solutions.
Veronese Ventures has a notable portfolio company, ArteraAI, which specializes in precision oncology. Roberto Veronese serves in an advisory role for this company, contributing his expertise in digital health and biotech. While other specific portfolio companies have not been publicly disclosed, the firm is actively involved in guiding startups that align with its investment focus.
ArteraAI exemplifies the type of innovative company that Veronese Ventures seeks to support, as it operates at the intersection of technology and healthcare. The firm’s commitment to enhancing product strategy and market integration positions it as a valuable partner for startups aiming to make significant advancements in healthcare.
Roberto Veronese - Founder / Solo GP. Roberto has over ten years of experience in digital health and biotech, with a strong focus on genomics and AI-driven precision medicine. He previously served as VP of Product and Design at Helix, where he led the consumer genomics and clinical product portfolio. Roberto has also been involved with GRAIL on their multi-cancer early detection test and currently advises at ArteraAI.
Roberto holds an executive education from prestigious institutions including MIT, Yale School of Management, Stanford School of Medicine, and Columbia Business School. He earned both a BA and MA in Philosophy from the University of Padova in Italy, which complements his analytical approach to product strategy and market integration.
To pitch Veronese Ventures, founders should visit their website at veronese.ventures. The firm prefers detailed decks that clearly outline the startup's vision, market strategy, and the role of AI in their healthcare solutions. While specific response time expectations are not provided, founders are encouraged to ensure their presentations are thorough and well-prepared.
In 2023, Veronese Ventures continues to expand its influence in the digital health and biotech sectors. The firm has been actively involved in guiding startups through product strategy and market integration, leveraging Roberto Veronese's extensive experience. Notably, Roberto serves in an advisory role at ArteraAI, contributing to its precision oncology initiatives.
Additionally, Veronese Ventures publishes insights through a Substack newsletter, providing valuable information to the startup community. This ongoing engagement highlights the firm's commitment to supporting innovative healthcare solutions.
What are the investment criteria for Veronese Ventures?
Veronese Ventures focuses on early- and mid-stage startups in the digital health, biotech, and precision medicine sectors. The firm emphasizes the application of AI in healthcare and seeks companies that can leverage insights from genomics to enhance their solutions.
How can founders pitch to Veronese Ventures?
Founders interested in pitching to Veronese Ventures can visit their website at veronese.ventures for more information on the application process. The firm encourages detailed presentations that outline the startup's vision, market strategy, and how they plan to utilize AI in their healthcare solutions.
What makes Veronese Ventures different from other investors?
Veronese Ventures combines angel investing with strategic advisory services, providing not only capital but also valuable insights into product strategy and market integration. This dual approach allows them to support startups more comprehensively than traditional investors.
What is the geographic scope of Veronese Ventures?
The firm primarily operates in North America, focusing on startups that are innovating in the digital health and biotech sectors. This geographic focus allows them to leverage local market insights and connections.
What is the typical check size for investments?
Veronese Ventures invests at various stages, including angel, pre-seed, seed, seed-plus, and series A. While specific check sizes are not disclosed, the firm is known for its flexibility in supporting startups at different funding stages.
What kind of post-investment involvement can founders expect?
Roberto Veronese provides advisory support to portfolio companies, focusing on product strategy, market research, and customer experience design. This involvement helps startups navigate challenges and optimize their market approach.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.